![Mark L. Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mark L.
Lewis is currently the Executive Chairman at Miroculus, Inc. He previously worked as the Director at Swift Biosciences, Inc. from 2017 to 2021.
He also held the position of General Manager & Vice President at BD Biosciences Clontech.
Mark L. Lewis active positions
| Companies | Position | Start |
|---|---|---|
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Chairman | 18/04/2022 |
Former positions of Mark L. Lewis
| Companies | Position | End |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Chief Executive Officer | 31/12/2017 |
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Health Technology |
Miroculus, Inc.
Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Technology Services |
- Stock Market
- Insiders
- Mark L. Lewis
